antibiotic/hemorrhage

This application is based on research conducted under contract with the United States Agency for International Development, Contract No. AID/CCP-3079-A-5022-00. This application is also based on United States Provisional Application No. 60/014,923, filed Apr. 5, 1996, from which Applicant claims the

BACKGROUND OF THE INVENTION Pseudomonas aeruginosa is known to be naturally resistant against most of antibiotics commonly used. Although there are only a few antibiotics to which the bacteria are sensitive, the use of these antibiotics in the therapy of infections due to Pseudomonas aeruginosa is

The present invention is directed to methods of and products for enabling the disinfecting or antiseptic protecting and substantially room temperature storing of normally dry bacterial-component-containing solid emulsions for pharmacological use with bleeding cuts, wounds, and abrasions and the

FIELD OF THE INVENTION The invention is in the field of clinical diagnostics. Particularly, the invention relates to the determination of the level of Procalcitonin (PCT) in a sample derived from a bodily fluid of a subject after an acute stroke or a transient ischemic attack. BACKGROUND OF THE

BRIEF SUMMARY OF THE INVENTION This invention relates to novel compositions of matter useful in the veterinary field for the treatment and prophylaxis of hemorrhagic colitis in swine. More particularly, it relates to therapeutic and prophylatic compositions containing one or more of the following

FIELD AND BACKGROUND OF THE INVENTION The present invention relates to a method, device, and pharmaceutical compositions, for the controlled removal of cells from the surface of viable tissue by continuous local application of a solution containing a proteolytic enzyme and, more particularly, to a

BACKGROUND A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition

BACKGROUND A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition

FIELD OF THE INVENTION This invention relates to dental flosses and picks. BACKGROUND Dental flosses and picks have long been used to clean the teeth and the gum margin. In the past, certain medicinal ingredients have been incorporated within the picks and floss e.g., fluoride to protect the tooth

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates generally to use of intravascular catheters. More specifically, it relates to the use of central venous catheters. Even more specifically, it relates to hemodialysis catheters such as non-tunneled which are short term